{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:49:26Z","timestamp":1792162166308,"version":"4.4.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12937-x","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:22:46Z","timestamp":1792160566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Why does siRNA delivery still fail in neurodegenerative diseases? Biological barriers, nanocarrier engineering, and future translational directions"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1127-9380","authenticated-orcid":false,"given":"G\u00fclfem","family":"Erbil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damla","family":"Aykora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metehan","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"12937_CR1","doi-asserted-by":"publisher","unstructured":"Muthukumar S, Babu HWS, Subramaniam MD (2026) An overview of neurodegenerative diseases. Fundamentals Brain Organoids Neurol Dis 141\u2013160. https:\/\/doi.org\/10.1016\/B978-0-443-29898-1.00019-8","DOI":"10.1016\/B978-0-443-29898-1.00019-8"},{"key":"12937_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-3-032-08576-4_9","volume":"1218","author":"S More","year":"2026","unstructured":"More S, Pandey R, Tungare K et al (2026) Advancements in Metal Bio-Nanocomposites for Neurodegenerative Diseases. Nanatechnol Life Sci Part F 1218:211\u2013231. https:\/\/doi.org\/10.1007\/978-3-032-08576-4_9","journal-title":"Nanatechnol Life Sci Part F"},{"key":"12937_CR3","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/CSHPERSPECT.A028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW (2017) Pathology of Neurodegenerative Diseases. Cold Spring Harb Perspect Biol 9:a028035. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"12937_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jfma.2026.03.072","volume":"15","author":"S-P Fan","year":"2026","unstructured":"Fan S-P, Liu P-C, Wang J-Z et al (2026) Epidemiological burden of Alzheimer\u2019s and Parkinson\u2019s diseases in East Asia: A comparative review of global burden of disease estimates and national registry data. J Formos Med Assoc 15:673\u2013687. https:\/\/doi.org\/10.1016\/j.jfma.2026.03.072","journal-title":"J Formos Med Assoc"},{"key":"12937_CR5","doi-asserted-by":"publisher","unstructured":"Bhati V, Prasad S, Kabra A (2025) RNA-based therapies for neurodegenerative disease: Targeting molecular mechanisms for disease modification. Mol Cell Neurosci 133. https:\/\/doi.org\/10.1016\/j.mcn.2025.104010","DOI":"10.1016\/j.mcn.2025.104010"},{"key":"12937_CR6","doi-asserted-by":"publisher","first-page":"1801362","DOI":"10.1002\/adma.201801362","volume":"30","author":"D Furtado","year":"2018","unstructured":"Furtado D, Bj\u00f6rnmalm M, Ayton S et al (2018) Overcoming the Blood\u2013Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases. Adv Mater 30:1801362. https:\/\/doi.org\/10.1002\/adma.201801362","journal-title":"Adv Mater"},{"key":"12937_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(24)00476-9","volume":"24","author":"JH Pedder","year":"2025","unstructured":"Pedder JH, Sonabend AM, Cearns MD et al (2025) Crossing the blood\u2013brain barrier: emerging therapeutic strategies for neurological disease. Lancet Neurol 24:246\u2013260. https:\/\/doi.org\/10.1016\/S1474-4422(24)00476-9","journal-title":"Lancet Neurol"},{"key":"12937_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","volume":"18","author":"RL Setten","year":"2019","unstructured":"Setten RL, Rossi JJ, Han Sping (2019) The current state and future directions of RNAi-based therapeutics. Nat Rev Drug Discov 18:421\u2013446. https:\/\/doi.org\/10.1038\/s41573-019-0017-4","journal-title":"Nat Rev Drug Discov"},{"key":"12937_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/S12951-023-02147-Z","volume":"21","author":"SS Ali Zaidi","year":"2023","unstructured":"Ali Zaidi SS, Fatima F, Ali Zaidi SA et al (2023) Engineering siRNA therapeutics: challenges and strategies. J Nanobiotechnol 21:381. https:\/\/doi.org\/10.1186\/S12951-023-02147-Z","journal-title":"J Nanobiotechnol"},{"key":"12937_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/PHARMACY12020058","volume":"12","author":"I Sehgal","year":"2024","unstructured":"Sehgal I, Eells K, Hudson I (2024) A Comparison of Currently Approved Small Interfering RNA (siRNA) Medications to Alternative Treatments by Costs, Indications, and Medicaid Coverage. Pharm (Basel) 12:58. https:\/\/doi.org\/10.3390\/PHARMACY12020058","journal-title":"Pharm (Basel)"},{"key":"12937_CR11","doi-asserted-by":"publisher","first-page":"100243","DOI":"10.1016\/J.DMD.2026.100243","volume":"54","author":"H Andersen","year":"2026","unstructured":"Andersen H, Hill R, Bell A et al (2026) Profiling RNA metabolism to understand tissue and subcellular clearance of therapeutic RNA. Drug Metab Dispos 54:100243. https:\/\/doi.org\/10.1016\/J.DMD.2026.100243","journal-title":"Drug Metab Dispos"},{"key":"12937_CR12","doi-asserted-by":"publisher","first-page":"595572","DOI":"10.2147\/IJN.S595572","volume":"21","author":"Y Jian","year":"2026","unstructured":"Jian Y, Ban M, Yan Z et al (2026) Stimuli-Responsive Nanocarriers for Transdermal siRNA Delivery: Mechanisms, Challenges, and Therapeutic Strategies. Int J Nanomed 21:595572. https:\/\/doi.org\/10.2147\/IJN.S595572","journal-title":"Int J Nanomed"},{"key":"12937_CR13","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/CM9.0000000000004061","volume":"139","author":"Q Jiang","year":"2026","unstructured":"Jiang Q, Fu J, An Y, Liu Y (2026) Therapeutic siRNA: Mechanisms, challenges, strategies, and clinical translation. Chin Med J (Engl) 139:1633\u20131648. https:\/\/doi.org\/10.1097\/CM9.0000000000004061;ISSUE:ISSUE:DOI","journal-title":"Chin Med J (Engl)"},{"key":"12937_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/HEP.20702","volume":"41","author":"DV Morrissey","year":"2005","unstructured":"Morrissey DV, Blanchard K, Shaw L et al (2005) Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 41:1349\u20131356. https:\/\/doi.org\/10.1002\/HEP.20702","journal-title":"Hepatology"},{"key":"12937_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/NAR\/GKAF1438","volume":"54","author":"D O\u2019Reilly","year":"2026","unstructured":"O\u2019Reilly D, Furgal RC, Ross VM et al (2026) Presence of phosphodiester backbone, but not nucleobases, in the guide\u2019s 3\u2032 terminal region is necessary for RISC loading and target cleavage in vitro and in vivo. Nucleic Acids Res 54:54. https:\/\/doi.org\/10.1093\/NAR\/GKAF1438","journal-title":"Nucleic Acids Res"},{"key":"12937_CR16","doi-asserted-by":"publisher","unstructured":"Davis SM, Hildebrand S, Macmillan HJ et al (2025) Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacy. Nucleic Acids Res 53. https:\/\/doi.org\/10.1093\/NAR\/GKAF479","DOI":"10.1093\/NAR\/GKAF479"},{"key":"12937_CR17","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1096\/FJ.13-228668","volume":"27","author":"J Zheng","year":"2013","unstructured":"Zheng J, Zhang L, Zhang J et al (2013) Single modification at position 14 of siRNA strand abolishes its gene-silencing activity by decreasing both RISC loading and target degradation. FASEB J 27:4017\u20134026. https:\/\/doi.org\/10.1096\/FJ.13-228668","journal-title":"FASEB J"},{"key":"12937_CR18","doi-asserted-by":"publisher","first-page":"117693","DOI":"10.1016\/J.BMC.2024.117693","volume":"104","author":"J Hayashi","year":"2024","unstructured":"Hayashi J, Ochi Y, Senpuku K et al (2024) Rational design of prodrug-type apoB-targeted siRNA for nuclease resistance improvement without compromising gene silencing potency. Bioorg Med Chem 104:117693. https:\/\/doi.org\/10.1016\/J.BMC.2024.117693","journal-title":"Bioorg Med Chem"},{"key":"12937_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1261\/RNA.30706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson AL, Burchard J, Leake D et al (2006) Position-specific chemical modification of siRNAs reduces off-target transcript silencing. RNA 12:1197\u20131205. https:\/\/doi.org\/10.1261\/RNA.30706","journal-title":"RNA"},{"key":"12937_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/MT.2010.266","volume":"19","author":"Y Huang","year":"2010","unstructured":"Huang Y, Hong J, Zheng S et al (2010) Elimination Pathways of Systemically Delivered siRNA. Mol Ther 19:381. https:\/\/doi.org\/10.1038\/MT.2010.266","journal-title":"Mol Ther"},{"key":"12937_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/17425247.2022.2093854","volume":"19","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Chu Y, Zhan C (2022) Protein corona: challenges and opportunities for targeted delivery of nanomedicines. Expert Opin Drug Deliv 19:833\u2013846. https:\/\/doi.org\/10.1080\/17425247.2022.2093854","journal-title":"Expert Opin Drug Deliv"},{"key":"12937_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2217\/NNM.14.69","volume":"10","author":"M Mahmoudi","year":"2015","unstructured":"Mahmoudi M, Sheibani S, Milani AS et al (2015) Crucial Role of the Protein Corona for the Specific Targeting of Nanoparticles. Nanomedicine 10:215\u2013226. https:\/\/doi.org\/10.2217\/NNM.14.69","journal-title":"Nanomedicine"},{"key":"12937_CR23","doi-asserted-by":"publisher","first-page":"2303266","DOI":"10.1002\/ADMA.202303266","volume":"36","author":"M Hu","year":"2024","unstructured":"Hu M, Li X, You Z et al (2024) Physiological Barriers and Strategies of Lipid-Based Nanoparticles for Nucleic Acid Drug Delivery. Adv Mater 36:2303266. https:\/\/doi.org\/10.1002\/ADMA.202303266;ISSUE:ISSUE:DOI","journal-title":"Adv Mater"},{"key":"12937_CR24","doi-asserted-by":"publisher","first-page":"114699","DOI":"10.1016\/J.JCONREL.2026.114699","volume":"392","author":"PM Panovich","year":"2026","unstructured":"Panovich PM, Ganesan A, Markey AI et al (2026) Engineered cargo-free nanoparticle decoys for phagocytic modulation of macrophages. J Controlled Release 392:114699. https:\/\/doi.org\/10.1016\/J.JCONREL.2026.114699","journal-title":"J Controlled Release"},{"key":"12937_CR25","doi-asserted-by":"publisher","unstructured":"Bhattacharjee B, Sandhanam K, Bezbaruah R et al (2026) Engineered and Surface-Modified Exosomes: Site-Specific Drug Delivery. Clin Potential Exosomes 121\u2013165. https:\/\/doi.org\/10.1201\/9781774919835-4","DOI":"10.1201\/9781774919835-4"},{"key":"12937_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCIB.2026.05.040","author":"C Xie","year":"2026","unstructured":"Xie C, Lynch I, Chen C, Guo Z (2026) Navigating the transcytosis highway: engineering protein coronas for enhanced drug delivery across the blood\u2013brain barrier. Sci Bull (Beijing). https:\/\/doi.org\/10.1016\/J.SCIB.2026.05.040","journal-title":"Sci Bull (Beijing)"},{"key":"12937_CR27","doi-asserted-by":"publisher","first-page":"124202","DOI":"10.1016\/J.BIOMATERIALS.2026.124202","volume":"333","author":"X Zhang","year":"2026","unstructured":"Zhang X, Ye Z, Cui S et al (2026) Human blood\u2013brain barrier tissue model to characterize lipid nanoparticle delivery and transport mechanisms. Biomaterials 333:124202. https:\/\/doi.org\/10.1016\/J.BIOMATERIALS.2026.124202","journal-title":"Biomaterials"},{"key":"12937_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/S13346-025-01887-9","volume":"16","author":"E Haro-Mart\u00ednez","year":"2025","unstructured":"Haro-Mart\u00ednez E, Muscolino E, Moral N et al (2025) Crossing the blood\u2013brain barrier: nanoparticle-based strategies for neurodegenerative disease therapy. Drug Delivery Translational Res 2025 16:3. https:\/\/doi.org\/10.1007\/S13346-025-01887-9","journal-title":"Drug Delivery Translational Res 2025"},{"key":"12937_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/CANCERS18121957","volume":"18","author":"F Moosavi","year":"2026","unstructured":"Moosavi F, Hassani B, Mortazavi M et al (2026) Protein Kinase Inhibitors as Regulators of ABC Transporters in Overcoming Cancer Multidrug Resistance: A Comprehensive Review of Recent Advances. Cancers 2026 18:18. https:\/\/doi.org\/10.3390\/CANCERS18121957","journal-title":"Cancers 2026"},{"key":"12937_CR30","doi-asserted-by":"publisher","unstructured":"Das NG, Das SK (2026) Mechanisms of transport across the blood\u2013brain barrier. Nanotherapeutics Treat Neurodegenerative Disorders 33\u201348. https:\/\/doi.org\/10.1016\/B978-0-443-33623-2.00019-2","DOI":"10.1016\/B978-0-443-33623-2.00019-2"},{"key":"12937_CR31","unstructured":"Sharma I, Singh B, Journal S (2026) Breaching the Blood\u2013Brain Barrier: Contemporary Strategies for Targeted Drug Delivery to the Central Nervous System. Stephens J Healthc Res 1"},{"key":"12937_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.biomaterials.2015.12.021","volume":"82","author":"M Concei\u00e7\u00e3o","year":"2016","unstructured":"Concei\u00e7\u00e3o M, Mendon\u00e7a L, N\u00f3brega C et al (2016) Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype. Biomaterials 82:124\u2013137. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.12.021","journal-title":"Biomaterials"},{"key":"12937_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/J.JCONREL.2018.04.034","volume":"279","author":"P Wang","year":"2018","unstructured":"Wang P, Zheng X, Guo Q et al (2018) Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer\u2019s disease. J Control Release 279:220\u2013233. https:\/\/doi.org\/10.1016\/J.JCONREL.2018.04.034","journal-title":"J Control Release"},{"key":"12937_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/J.ACTBIO.2025.10.018","volume":"207","author":"H Tong","year":"2025","unstructured":"Tong H, Ma Z, Li D et al (2025) Tuning the polyethylene glycol-lipid anchor length of lipid nanoparticles to enhance brain-targeted siRNA delivery. Acta Biomater 207:591\u2013602. https:\/\/doi.org\/10.1016\/J.ACTBIO.2025.10.018","journal-title":"Acta Biomater"},{"key":"12937_CR35","doi-asserted-by":"publisher","unstructured":"De Martini LB, Valori CF, Morrone M et al (2026) Intranasal vs. Device-Assisted Drug Delivery: Advantages and Limitations for the Delivery of Biopharmaceuticals to the CNS. Pharmaceutics 2026. 18:18. https:\/\/doi.org\/10.3390\/PHARMACEUTICS18040484","DOI":"10.3390\/PHARMACEUTICS18040484"},{"issue":"1 63","key":"12937_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/S12035-025-05417-Z","volume":"63","author":"U Kochman","year":"2025","unstructured":"Kochman U, Sitka H, Ku\u017aniar J et al (2025) Targeted Nanoparticles for Drug Delivery Across the Blood\u2013Brain Barrier in Early and Late Stages of Alzheimer\u2019s Disease: A Review. Mol Neurobiol 2025 63(1 63):75\u2013. https:\/\/doi.org\/10.1007\/S12035-025-05417-Z","journal-title":"Mol Neurobiol 2025"},{"key":"12937_CR37","doi-asserted-by":"publisher","unstructured":"Batheja S, Pallem KLS, Gupta U (2026) Surface engineering of drug carriers. Functionalized Drug Delivery Syst 25\u201360. https:\/\/doi.org\/10.1016\/B978-0-443-33304-0.00003-4","DOI":"10.1016\/B978-0-443-33304-0.00003-4"},{"key":"12937_CR38","doi-asserted-by":"publisher","unstructured":"Adnan SB, Lim F, Ahmad H et al (2026) Peptide-Based Nanocarriers for Targeted Drug Delivery: Recent Advances, Strategies, and Therapeutic Frontiers. Int J Nanomed 21. https:\/\/doi.org\/10.2147\/IJN.S588558","DOI":"10.2147\/IJN.S588558"},{"key":"12937_CR39","doi-asserted-by":"publisher","first-page":"394","DOI":"10.20517\/EVCNA.2025.158","volume":"7","author":"Y Fang","year":"2026","unstructured":"Fang Y, Hao X, Fang B (2026) Extracellular vesicle therapeutics in Alzheimer\u2019s disease: mechanisms, progress, and prospects. Extracell Vesicles Circ Nucl Acids 7:394\u2013424. https:\/\/doi.org\/10.20517\/EVCNA.2025.158","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"12937_CR40","doi-asserted-by":"publisher","unstructured":"Zhang C, Zhang J, Wang Y et al (2026) Neuron-Targeted Exosomal Delivery of siRNA Against RIPK3 Slows Neurodegenerative Progression in Alzheimer\u2019s Disease. https:\/\/doi.org\/10.1002\/ADVS.76558. Advanced Science e76558","DOI":"10.1002\/ADVS.76558"},{"key":"12937_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-025-60959-z","volume":"16","author":"JM Johansson","year":"2025","unstructured":"Johansson JM, Du Rietz H, Hedlund H et al (2025) Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol. Nat Commun 2025 16:1. https:\/\/doi.org\/10.1038\/s41467-025-60959-z","journal-title":"Nat Commun 2025"},{"key":"12937_CR42","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tibtech.2018.01.006","volume":"36","author":"M Zheng","year":"2018","unstructured":"Zheng M, Tao W, Zou Y et al (2018) Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy. Trends Biotechnol 36:562\u2013575. https:\/\/doi.org\/10.1016\/j.tibtech.2018.01.006","journal-title":"Trends Biotechnol"},{"key":"12937_CR43","doi-asserted-by":"publisher","unstructured":"Menge J, Yang C, Weitz DA, Jahnke K (2026) Engineering the biophysical properties of lipid nanostructures for drug delivery. Communications Materials 2026 7:1 7:25-. https:\/\/doi.org\/10.1038\/s43246-026-01073-5","DOI":"10.1038\/s43246-026-01073-5"},{"key":"12937_CR44","doi-asserted-by":"publisher","first-page":"e70337","DOI":"10.1002\/MCO2","volume":"6","author":"Z Xu","year":"2025","unstructured":"Xu Z, Xie Y, Chen W, Deng W (2025) Nanocarrier-Based Systems for Targeted Delivery: Current Challenges and Future Directions. MedComm (Beijing) 6:e70337. https:\/\/doi.org\/10.1002\/MCO270337;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"MedComm (Beijing)"},{"key":"12937_CR45","doi-asserted-by":"publisher","first-page":"104776","DOI":"10.1016\/J.ETAP.2025.104776","volume":"118","author":"T Ito","year":"2025","unstructured":"Ito T, Ikuno Y, Udagawa O et al (2025) Human neurons are susceptible to the internalization of small-sized nanoplastics. Environ Toxicol Pharmacol 118:104776. https:\/\/doi.org\/10.1016\/J.ETAP.2025.104776","journal-title":"Environ Toxicol Pharmacol"},{"key":"12937_CR46","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1039\/D5EN00291E","volume":"12","author":"Y Wang","year":"2025","unstructured":"Wang Y, Huang G, Liang X et al (2025) Microglial Clearance of Alzheimer\u2019s Amyloid-Beta Obstructed by Nanoplastics. Environ Sci Nano 12:3247\u20133260. https:\/\/doi.org\/10.1039\/D5EN00291E","journal-title":"Environ Sci Nano"},{"key":"12937_CR47","doi-asserted-by":"publisher","first-page":"20947","DOI":"10.1039\/D5NR01079A","volume":"17","author":"G Zavala","year":"2025","unstructured":"Zavala G, Berr\u00edos P, Sandoval F et al (2025) Royal jelly derived extracellular vesicles modulate microglial nanomechanics and inflammatory responses. Nanoscale 17:20947\u201320959. https:\/\/doi.org\/10.1039\/D5NR01079A","journal-title":"Nanoscale"},{"key":"12937_CR48","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1021\/ACS.MOLPHARMACEUT.5C00285","volume":"22","author":"J Cheng","year":"2025","unstructured":"Cheng J, Kandimalla KK (2025) Intracellular Trafficking of Cationic Bicelles and siRNA Cargo in an In Vitro Blood\u2013Brain Barrier Model. Mol Pharm 22:4009\u20134018. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.5C00285","journal-title":"Mol Pharm"},{"key":"12937_CR49","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1039\/D3NR05738K","volume":"16","author":"J Majer","year":"2024","unstructured":"Majer J, Kindermann M, Pinkas D et al (2024) Cellular uptake and fate of cationic polymer-coated nanodiamonds delivering siRNA: a mechanistic study. Nanoscale 16:2490\u20132503. https:\/\/doi.org\/10.1039\/D3NR05738K","journal-title":"Nanoscale"},{"key":"12937_CR50","doi-asserted-by":"publisher","unstructured":"Choezom D, Notter S, Griebel T et al (2025) Macropinocytic Uptake and pH-Responsive Endolysosomal Processing Drive Sustained Chemotherapeutic Efficacy of High-Load Core@Shell Nanocarriers in Colorectal Cancer. Small Sci 6. https:\/\/doi.org\/10.1002\/SMSC.202500470","DOI":"10.1002\/SMSC.202500470"},{"key":"12937_CR51","doi-asserted-by":"publisher","first-page":"100420","DOI":"10.1016\/J.CELBIO.2026.100420","volume":"0","author":"T Liu","year":"2026","unstructured":"Liu T, Yang Y, Yu W et al (2026) Engineering biomaterials-based nanoplatforms for precision-targeted therapeutic delivery. Cell Biomaterials 0:100420. https:\/\/doi.org\/10.1016\/J.CELBIO.2026.100420","journal-title":"Cell Biomaterials"},{"key":"12937_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/BIOM16010156","volume":"16","author":"D K\u0119dzia","year":"2026","unstructured":"K\u0119dzia D, Galita G, Majsterek I, Rozp\u0119dek-Kami\u0144ska W (2026) Microglia, Astrocytes, and Oligodendrocytes in Parkinson\u2019s Disease: Neuroinflammatory Crosstalk and Emerging Therapeutic Strategies. Biomolecules 2026 16:16. https:\/\/doi.org\/10.3390\/BIOM16010156","journal-title":"Biomolecules 2026"},{"key":"12937_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.17712\/1658-3183.2786","volume":"31","author":"MA Almikhlafi","year":"2026","unstructured":"Almikhlafi MA (2026) Neuroinflammation at the Crossroads of Neurodegeneration: The Roles of Microglia and Astrocytes in Parkinson\u2019s Disease, Alzheimer\u2019s Disease, and Multiple Sclerosis. Neurosciences 31:89. https:\/\/doi.org\/10.17712\/1658-3183.2786","journal-title":"Neurosciences"},{"key":"12937_CR54","doi-asserted-by":"publisher","first-page":"2309225","DOI":"10.1002\/ADMA.202309225","volume":"36","author":"WT Ralvenius","year":"2024","unstructured":"Ralvenius WT, Andresen JL, Huston MM et al (2024) Nanoparticle-Mediated Delivery of Anti-PU.1 siRNA via Localized Intracisternal Administration Reduces Neuroinflammation. Adv Mater 36:2309225. https:\/\/doi.org\/10.1002\/ADMA.202309225","journal-title":"Adv Mater"},{"key":"12937_CR55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/NBT.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341\u2013345. https:\/\/doi.org\/10.1038\/NBT.1807","journal-title":"Nat Biotechnol"},{"key":"12937_CR56","doi-asserted-by":"publisher","first-page":"10448","DOI":"10.1021\/ACSANM.5C05449","volume":"9","author":"S Nikhar","year":"2026","unstructured":"Nikhar S, Jahan A, Mahato T, Giri AS (2026) Peptide and Antibody Functionalized Nanoparticles: Active Targeting Strategies for Next-Generation Contrast Agents and Drug Delivery Systems. ACS Appl Nano Mater 9:10448\u201310477. https:\/\/doi.org\/10.1021\/ACSANM.5C05449","journal-title":"ACS Appl Nano Mater"},{"key":"12937_CR57","doi-asserted-by":"publisher","unstructured":"Noh MY, Kwon HS, Kwon MS et al (2025) Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions. Molecular Neurodegeneration 2025 20:1 20:82-. https:\/\/doi.org\/10.1186\/S13024-025-00867-4","DOI":"10.1186\/S13024-025-00867-4"},{"key":"12937_CR58","doi-asserted-by":"publisher","unstructured":"Rocchi A, Marchetti L, Decuzzi P et al (2026) Controlling nanoparticle targeting: from physicochemical design to molecular recognition. https:\/\/doi.org\/10.1080\/17435889.2026.2688999. Nanomedicine","DOI":"10.1080\/17435889.2026.2688999"},{"key":"12937_CR59","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-25-01562","author":"DA Domingo-Lopez","year":"2026","unstructured":"Domingo-Lopez DA, de Armas MRA, Martin-Salda\u00f1a S (2026) Extracellular matrix remodeling therapeutic strategies to tackle central nervous system diseases. Neural Regen Res. https:\/\/doi.org\/10.4103\/NRR.NRR-D-25-01562","journal-title":"Neural Regen Res"},{"key":"12937_CR60","doi-asserted-by":"publisher","first-page":"50142","DOI":"10.1021\/ACSAMI.5C10918","volume":"17","author":"J Cui","year":"2025","unstructured":"Cui J, Wang K, Wu Z et al (2025) Designing Protein-Based Nanoparticles for Therapeutic Applications. ACS Appl Mater Interfaces 17:50142\u201350167. https:\/\/doi.org\/10.1021\/ACSAMI.5C10918","journal-title":"ACS Appl Mater Interfaces"},{"key":"12937_CR61","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1055\/A-2871-6002","volume":"08","author":"D He","year":"2026","unstructured":"He D, Wang Y, Ling X et al (2026) Breaking Down Intracellular Barriers: Advanced Nanocarriers for Cytosolic Small-Interfering RNA Delivery. Pharm Fronts 08:e109\u2013e128. https:\/\/doi.org\/10.1055\/A-2871-6002","journal-title":"Pharm Fronts"},{"key":"12937_CR62","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1021\/ACSNANO.5C18112","volume":"20","author":"GS Chahal","year":"2026","unstructured":"Chahal GS, Helbig KJ, Parton RG, Monson EA (2026) The Biology of Endosomal Escape: Strategies for Enhanced Delivery of Therapeutics. ACS Nano 20:1789\u20131813. https:\/\/doi.org\/10.1021\/ACSNANO.5C18112","journal-title":"ACS Nano"},{"issue":"1","key":"12937_CR63","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/S12951-026-04372-8","volume":"24","author":"W Lin","year":"2026","unstructured":"Lin W, Qiao E, Wang Z et al (2026) The application of drug delivery systems based on targeted protein degradation chimeras in disease treatment strategies. J Nanobiotechnol 2026 24(1):496\u2013. https:\/\/doi.org\/10.1186\/S12951-026-04372-8","journal-title":"J Nanobiotechnol 2026"},{"key":"12937_CR64","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/NBT.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron J, Querbes W, Zeigerer A et al (2013) Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat Biotechnol 31:638\u2013646. https:\/\/doi.org\/10.1038\/NBT.2612","journal-title":"Nat Biotechnol"},{"key":"12937_CR65","doi-asserted-by":"crossref","unstructured":"Jain N, Mandaloi AS, Mishra A et al (2026) Role of Polymers in Nucleic Acid Delivery. Nanotechnology for Nucleic Acid Delivery 99\u2013140. https:\/\/doi.org\/10.1201\/9781998511853-4\/ROLE-POLYMERS-NUCLEIC-ACID-DELIVERY-NIMISHA-JAIN-AVINASH-SINGH-MANDALOI-ANKIT-MISHRA-PRANALI-MISHRA-PANKAJ-SHARMA","DOI":"10.1201\/9781998511853-4"},{"key":"12937_CR66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/S13346-025-02040-2","volume":"16","author":"N Yadav","year":"2026","unstructured":"Yadav N, Debnath N, Das S (2026) Stimuli-responsive nanocarriers for targeted mRNA therapeutics: a paradigm shift in mRNA delivery for biomedical applications. Drug Delivery Translational Res 2026 16:6. https:\/\/doi.org\/10.1007\/S13346-025-02040-2","journal-title":"Drug Delivery Translational Res 2026"},{"key":"12937_CR67","doi-asserted-by":"publisher","unstructured":"Henry N, Kaur A, Chen R (2026) Bioinspired synthetic strategies for enhanced cell membrane interactions for targeted delivery of biomacromolecules. Expert Opin Drug Deliv 1\u201322. https:\/\/doi.org\/10.1080\/17425247.2026.2702442","DOI":"10.1080\/17425247.2026.2702442"},{"key":"12937_CR68","doi-asserted-by":"publisher","unstructured":"Du Rietz H, Hedlund H, Wilhelmson S et al (2020) Imaging small molecule-induced endosomal escape of siRNA. Nature Communications 2020 11:1 11:1809-. https:\/\/doi.org\/10.1038\/s41467-020-15300-1","DOI":"10.1038\/s41467-020-15300-1"},{"key":"12937_CR69","doi-asserted-by":"publisher","unstructured":"Munson MJ, O\u2019Driscoll G, Silva AM et al (2021) A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery. Commun Biol 4. https:\/\/doi.org\/10.1038\/S42003-021-01728-8","DOI":"10.1038\/S42003-021-01728-8"},{"key":"12937_CR70","doi-asserted-by":"publisher","unstructured":"Bader J, R\u00fcedi P, Mantella V et al (2025) Loading of Extracellular Vesicles with Nucleic Acids via Hybridization with Non-Lamellar Liquid Crystalline Lipid Nanoparticles. Adv Sci (Weinh) 12. https:\/\/doi.org\/10.1002\/ADVS.202404860","DOI":"10.1002\/ADVS.202404860"},{"key":"12937_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-51343-4","volume":"15","author":"T Tanaka","year":"2024","unstructured":"Tanaka T, Yano T, Usuki S et al (2024) Endocytosed dsRNAs induce lysosomal membrane permeabilization that allows cytosolic dsRNA translocation for Drosophila RNAi responses. Nat Commun 2024 15:1. https:\/\/doi.org\/10.1038\/s41467-024-51343-4","journal-title":"Nat Commun 2024"},{"key":"12937_CR72","doi-asserted-by":"publisher","first-page":"102631","DOI":"10.1016\/J.OMTN.2025.102631","volume":"36","author":"F He\u00df","year":"2025","unstructured":"He\u00df F, Odenthal M, Wasserburger-Zichel E et al (2025) A dual fluorescence-based reporter assay for real-time determination of siRNA- and antisense oligonucleotide-mediated knockdown. Mol Ther Nucleic Acids 36:102631. https:\/\/doi.org\/10.1016\/J.OMTN.2025.102631","journal-title":"Mol Ther Nucleic Acids"},{"key":"12937_CR73","doi-asserted-by":"publisher","first-page":"10649","DOI":"10.1039\/C5NR08365F","volume":"8","author":"S Itakura","year":"2016","unstructured":"Itakura S, Hama S, Matsui R, Kogure K (2016) Effective cytoplasmic release of siRNA from liposomal carriers by controlling the electrostatic interaction of siRNA with a charge-invertible peptide, in response to cytoplasmic pH. Nanoscale 8:10649\u201310658. https:\/\/doi.org\/10.1039\/C5NR08365F","journal-title":"Nanoscale"},{"key":"12937_CR74","doi-asserted-by":"publisher","first-page":"1903637","DOI":"10.1002\/ADMA.201903637","volume":"31","author":"B Kim","year":"2019","unstructured":"Kim B, Park JH, Sailor MJ (2019) Rekindling RNAi Therapy: Materials Design Requirements for. Vivo siRNA Delivery Adv Mater 31:1903637. https:\/\/doi.org\/10.1002\/ADMA.201903637","journal-title":"Vivo siRNA Delivery Adv Mater"},{"key":"12937_CR75","doi-asserted-by":"publisher","first-page":"102938","DOI":"10.1016\/j.omtn.2026.102938","volume":"37","author":"E Shcherbinina","year":"2026","unstructured":"Shcherbinina E, Fong M, Biscans A, Sarshad AA (2026) Argonaute and small RNAs in the nucleus: Mediators of gene silencing and activation. Mol Ther Nucleic Acids 37:102938. https:\/\/doi.org\/10.1016\/j.omtn.2026.102938","journal-title":"Mol Ther Nucleic Acids"},{"key":"12937_CR76","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1208\/S12248-010-9210-4","volume":"12","author":"J Wang","year":"2010","unstructured":"Wang J, Lu Z, Wientjes MG, Au JLS (2010) Delivery of siRNA Therapeutics: Barriers and Carriers. AAPS J 12:492. https:\/\/doi.org\/10.1208\/S12248-010-9210-4","journal-title":"AAPS J"},{"key":"12937_CR77","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/NRD2742","volume":"8","author":"KA Whitehead","year":"2009","unstructured":"Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8:129. https:\/\/doi.org\/10.1038\/NRD2742","journal-title":"Nat Rev Drug Discov"},{"key":"12937_CR78","doi-asserted-by":"publisher","first-page":"2402362","DOI":"10.1002\/SMLL","volume":"20","author":"Y Liu","year":"2024","unstructured":"Liu Y, He F, Chen L et al (2024) Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer. Small 20:2402362. https:\/\/doi.org\/10.1002\/SMLL.202402362;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"Small"},{"key":"12937_CR79","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/S11095-007-9303-7","volume":"24","author":"LN Patel","year":"2007","unstructured":"Patel LN, Zaro JL, Shen WC (2007) Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res 24:1977\u20131992. https:\/\/doi.org\/10.1007\/S11095-007-9303-7","journal-title":"Pharm Res"},{"key":"12937_CR80","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/NRD2742","volume":"8","author":"KA Whitehead","year":"2009","unstructured":"Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8:129\u2013138. https:\/\/doi.org\/10.1038\/NRD2742","journal-title":"Nat Rev Drug Discov"},{"key":"12937_CR81","doi-asserted-by":"publisher","first-page":"15096","DOI":"10.1021\/JACS.4C00691","volume":"146","author":"J Wang","year":"2024","unstructured":"Wang J, Chen P (2024) Engineering Biomimetic Protein Camouflage for Delivering Peptide\/siRNA Nanocomplexes. J Am Chem Soc 146:15096\u201315107. https:\/\/doi.org\/10.1021\/JACS.4C00691","journal-title":"J Am Chem Soc"},{"key":"12937_CR82","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/NATURE05901","volume":"448","author":"P Kumar","year":"2007","unstructured":"Kumar P, Wu H, McBride JL et al (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448:39\u201343. https:\/\/doi.org\/10.1038\/NATURE05901","journal-title":"Nature"},{"key":"12937_CR83","doi-asserted-by":"publisher","first-page":"100442","DOI":"10.1016\/J.MTNANO.2023.100442","volume":"25","author":"C Qiu","year":"2024","unstructured":"Qiu C, Liang ST, Tu QC et al (2024) Enhanced tumor penetration across the blood-brain barrier: endoplasmic reticulum membrane hybrid siRNA nanoplexes. Mater Today Nano 25:100442. https:\/\/doi.org\/10.1016\/J.MTNANO.2023.100442","journal-title":"Mater Today Nano"},{"key":"12937_CR84","doi-asserted-by":"publisher","first-page":"149ra119","DOI":"10.1126\/SCITRANSLMED.3003594","volume":"4","author":"EA Nance","year":"2012","unstructured":"Nance EA, Woodworth GF, Sailor KA et al (2012) A Dense Poly(ethylene glycol) Coating Improves Penetration of Large Polymeric Nanoparticles within Brain Tissue. Sci Transl Med 4:149ra119. https:\/\/doi.org\/10.1126\/SCITRANSLMED.3003594","journal-title":"Sci Transl Med"},{"key":"12937_CR85","doi-asserted-by":"publisher","first-page":"32549","DOI":"10.1039\/D1RA04293A","volume":"11","author":"H Xiao","year":"2021","unstructured":"Xiao H, Han S, Baigude H (2021) Regulation of microglia polarization via mannose receptor-mediated delivery of siRNA by ligand-functionalized DoGo LNP. RSC Adv 11:32549. https:\/\/doi.org\/10.1039\/D1RA04293A","journal-title":"RSC Adv"},{"key":"12937_CR86","doi-asserted-by":"publisher","first-page":"102065","DOI":"10.1016\/J.OMTN.2023.102065","volume":"34","author":"H Xiao","year":"2023","unstructured":"Xiao H, Amarsaikhan O, Zhao Y et al (2023) Astrocyte-targeted siRNA delivery by adenosine-functionalized LNP in mouse TBI model. Mol Ther Nucleic Acids 34:102065. https:\/\/doi.org\/10.1016\/J.OMTN.2023.102065","journal-title":"Mol Ther Nucleic Acids"},{"key":"12937_CR87","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/S11095-025-03890-8","volume":"42","author":"ZR Lu","year":"2025","unstructured":"Lu ZR, Sun D (2025) Mechanism of pH-sensitive Amphiphilic Endosomal Escape of Ionizable Lipid Nanoparticles for Cytosolic Nucleic Acid Delivery. Pharm Res 42:1065. https:\/\/doi.org\/10.1007\/S11095-025-03890-8","journal-title":"Pharm Res"},{"key":"12937_CR88","doi-asserted-by":"publisher","unstructured":"Pattipeiluhu R, Zeng Y, Hendrix MMRM et al (2024) Liquid crystalline inverted lipid phases encapsulating siRNA enhance lipid nanoparticle mediated transfection. Nat Commun 15. https:\/\/doi.org\/10.1038\/S41467-024-45666-5","DOI":"10.1038\/S41467-024-45666-5"},{"key":"12937_CR89","doi-asserted-by":"publisher","unstructured":"Hedlund H, Du Rietz H, Johansson JM et al (2023) Single-cell quantification and dose-response of cytosolic siRNA delivery. Nature Communications 2023 14:1 14:1075-. https:\/\/doi.org\/10.1038\/s41467-023-36752-1","DOI":"10.1038\/s41467-023-36752-1"},{"key":"12937_CR90","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.2174\/1381612821666150531164540","volume":"21","author":"HY Xue","year":"2015","unstructured":"Xue HY, Guo P, Wen W-C, Wong HL (2015) Lipid-Based Nanocarriers for RNA Delivery. Curr Pharm Des 21:3140. https:\/\/doi.org\/10.2174\/1381612821666150531164540","journal-title":"Curr Pharm Des"},{"key":"12937_CR91","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41573-024-00977-6","volume":"23","author":"PR Cullis","year":"2024","unstructured":"Cullis PR, Felgner PL (2024) The 60-year evolution of lipid nanoparticles for nucleic acid delivery. Nat Reviews Drug Discovery 2024 23:9. https:\/\/doi.org\/10.1038\/s41573-024-00977-6","journal-title":"Nat Reviews Drug Discovery 2024"},{"key":"12937_CR92","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/NAT","volume":"28","author":"JA Kulkarni","year":"2018","unstructured":"Kulkarni JA, Van Der Cullis PR (2018) Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility. Nucleic Acid Ther 28:146\u2013157. https:\/\/doi.org\/10.1089\/NAT2018.0721;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"Nucleic Acid Ther"},{"key":"12937_CR93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMOA1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD et al (2018) Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. N Engl J Med 379:11\u201321. https:\/\/doi.org\/10.1056\/NEJMOA1716153;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"N Engl J Med"},{"key":"12937_CR94","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/17425247.2023.2153832","volume":"20","author":"A De","year":"2023","unstructured":"De A, Ko YT (2023) A tale of nucleic acid\u2013ionizable lipid nanoparticles: Design and manufacturing technology and advancement. Expert Opin Drug Deliv 20:75\u201391. https:\/\/doi.org\/10.1080\/17425247.2023.2153832","journal-title":"Expert Opin Drug Deliv"},{"key":"12937_CR95","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1039\/D3LC00821E","volume":"24","author":"S Mehraji","year":"2024","unstructured":"Mehraji S, DeVoe DL (2024) Microfluidic synthesis of lipid-based nanoparticles for drug delivery: recent advances and opportunities. Lab Chip 24:1154\u20131174. https:\/\/doi.org\/10.1039\/D3LC00821E","journal-title":"Lab Chip"},{"key":"12937_CR96","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1021\/ACSMATERIALSAU.3C00032","volume":"3","author":"M Mehta","year":"2023","unstructured":"Mehta M, Bui TA, Yang X et al (2023) Lipid-Based Nanoparticles for Drug\/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development. ACS Mater Au 3:600\u2013619. https:\/\/doi.org\/10.1021\/ACSMATERIALSAU.3C00032","journal-title":"ACS Mater Au"},{"key":"12937_CR97","doi-asserted-by":"publisher","unstructured":"Vogelaar A, Marcotte S, Cheng J et al (2023) Use of Microfluidics to Prepare Lipid-Based Nanocarriers. Pharmaceutics 2023, Vol 15, 15:. https:\/\/doi.org\/10.3390\/PHARMACEUTICS15041053","DOI":"10.3390\/PHARMACEUTICS15041053"},{"key":"12937_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2026.115538","author":"S Guerrero","year":"2026","unstructured":"Guerrero S, Hassan N, Salas-Huenuleo E et al (2026) Apolipoprotein E-enriched protein corona enhances the blood\u2013brain barrier transport of \u03b2-sheet-breaker peptide-functionalized gold nanoparticles. Colloids Surf B Biointerfaces. https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115538. 262:","journal-title":"Colloids Surf B Biointerfaces"},{"key":"12937_CR99","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41563-024-02114-5","volume":"24","author":"C Wang","year":"2025","unstructured":"Wang C, Xue Y, Markovic T et al (2025) Blood\u2013brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nat Mater 2025 24:10. https:\/\/doi.org\/10.1038\/s41563-024-02114-5","journal-title":"Nat Mater 2025"},{"key":"12937_CR100","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/ACS.NANOLETT.4C05186","volume":"25","author":"EL Han","year":"2025","unstructured":"Han EL, Tang S, Kim D et al (2025) Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain. Nano Lett 25:800\u2013810. https:\/\/doi.org\/10.1021\/ACS.NANOLETT.4C05186","journal-title":"Nano Lett"},{"issue":"4","key":"12937_CR101","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard SA, Siegwart DJ (2023) Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat Reviews Mater 2023 8(4):282\u2013300. https:\/\/doi.org\/10.1038\/s41578-022-00529-7","journal-title":"Nat Reviews Mater 2023"},{"key":"12937_CR102","doi-asserted-by":"publisher","first-page":"e3672","DOI":"10.1002\/JGM.3672","volume":"26","author":"JJ Friesen","year":"2024","unstructured":"Friesen JJ, Blakney AK (2024) Trends in the synthetic polymer delivery of RNA. J Gene Med 26:e3672. https:\/\/doi.org\/10.1002\/JGM.3672;WGROUP:STRING:PUBLICATION","journal-title":"J Gene Med"},{"key":"12937_CR103","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1021\/ACS.MOLPHARMACEUT.0C01238","volume":"18","author":"MCP Mendon\u00e7a","year":"2021","unstructured":"Mendon\u00e7a MCP, Kont A, Aburto MR et al (2021) Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System. Mol Pharm 18:1491. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.0C01238","journal-title":"Mol Pharm"},{"key":"12937_CR104","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1039\/D4PY00124A","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Tian R, Xu J et al (2024) Recent developments of polymeric delivery systems in gene therapeutics. Polym Chem 15:1908\u20131931. https:\/\/doi.org\/10.1039\/D4PY00124A","journal-title":"Polym Chem"},{"issue":"12 14","key":"12937_CR105","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1007\/S13346-024-01585-Y","volume":"14","author":"JR Maga\u00f1a Rodriguez","year":"2024","unstructured":"Maga\u00f1a Rodriguez JR, Guerra-Rebollo M, Borr\u00f3s S, Fornaguera C (2024) Nucleic acid-loaded poly(beta-aminoester) nanoparticles for cancer nano-immuno therapeutics: the good, the bad, and the future. Drug Delivery Translational Res 2024 14(12 14):3477\u20133493. https:\/\/doi.org\/10.1007\/S13346-024-01585-Y","journal-title":"Drug Delivery Translational Res 2024"},{"key":"12937_CR106","doi-asserted-by":"publisher","first-page":"124545","DOI":"10.1016\/J.IJPHARM.2024.124545","volume":"663","author":"NK Dastgerdi","year":"2024","unstructured":"Dastgerdi NK, Dastgerdi NK, Bayraktutan H et al (2024) Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems. Int J Pharm 663:124545. https:\/\/doi.org\/10.1016\/J.IJPHARM.2024.124545","journal-title":"Int J Pharm"},{"key":"12937_CR107","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1021\/NL9009793","volume":"9","author":"JS Lee","year":"2009","unstructured":"Lee JS, Green JJ, Love KT et al (2009) Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett 9:2402\u20132406. https:\/\/doi.org\/10.1021\/NL9009793","journal-title":"Nano Lett"},{"key":"12937_CR108","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1039\/C3CC40718G","volume":"49","author":"KL Kozielski","year":"2013","unstructured":"Kozielski KL, Tzeng SY, Green JJ (2013) A bioreducible linear poly(\u03b2-amino ester) for siRNA delivery. Chem Commun 49:5319\u20135321. https:\/\/doi.org\/10.1039\/C3CC40718G","journal-title":"Chem Commun"},{"key":"12937_CR109","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/WNAN.1233;REQUESTEDJOURNAL:JOURNAL:19390041","volume":"5","author":"KL Kozielski","year":"2013","unstructured":"Kozielski KL, Tzeng SY, Green JJ (2013) Bioengineered nanoparticles for siRNA delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5:449\u2013468. https:\/\/doi.org\/10.1002\/WNAN.1233;REQUESTEDJOURNAL:JOURNAL:19390041","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"4","key":"12937_CR110","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s42254-026-00922-z","volume":"8","author":"J Zhou","year":"2026","unstructured":"Zhou J, Schuck PJ, Jin D (2026) Upconverting nanoparticles for biomedical applications. Nat Reviews Phys 2026 8(4):195\u2013207. https:\/\/doi.org\/10.1038\/s42254-026-00922-z","journal-title":"Nat Reviews Phys 2026"},{"key":"12937_CR111","doi-asserted-by":"publisher","first-page":"e70607","DOI":"10.1111\/ACEL.70607","volume":"25","author":"X Huang","year":"2026","unstructured":"Huang X, Li Q, Tao G et al (2026) Engineering Extracellular Vesicles for Anti-Aging Therapy: Mechanisms, Applications, and Perspectives. Aging Cell 25:e70607. https:\/\/doi.org\/10.1111\/ACEL.70607;ISSUE:ISSUE:DOI","journal-title":"Aging Cell"},{"key":"12937_CR112","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/NATURE22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, Lebleu VS, Sugimoto H et al (2017) Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546:498\u2013503. https:\/\/doi.org\/10.1038\/NATURE22341","journal-title":"Nature"},{"key":"12937_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12951-026-04404-3","volume":"24","author":"Y Hong","year":"2026","unstructured":"Hong Y, Hu S, Yu Z et al (2026) Surface engineering of extracellular vesicles: trends, strategies, and applications in diagnosis and therapy. J Nanobiotechnol 2026 24:1. https:\/\/doi.org\/10.1186\/S12951-026-04404-3","journal-title":"J Nanobiotechnol 2026"},{"key":"12937_CR114","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.2147\/IJN.S464249","volume":"19","author":"M Bahadorani","year":"2024","unstructured":"Bahadorani M, Nasiri M, Dellinger K et al (2024) Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies. Int J Nanomed 19:7137\u20137164. https:\/\/doi.org\/10.2147\/IJN.S464249","journal-title":"Int J Nanomed"},{"key":"12937_CR115","doi-asserted-by":"publisher","unstructured":"Iqbal U, Hwang RW, Costain WJ (2026) Recent Developments in Lipid Nanoparticle-Mediated Delivery of Biotherapeutics and Gene Therapy Across the Blood\u2013Brain Barrier. 40:3 BioDrugs 2026. https:\/\/doi.org\/10.1007\/S40259-026-00782-0","DOI":"10.1007\/S40259-026-00782-0"},{"key":"12937_CR116","doi-asserted-by":"publisher","unstructured":"Verma N, Arora S (2025) Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions. Pharmaceutics 2025, Vol 17, 17:. https:\/\/doi.org\/10.3390\/PHARMACEUTICS17080990","DOI":"10.3390\/PHARMACEUTICS17080990"},{"key":"12937_CR117","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.2174\/0109298673309011240606095639\/CITE\/REFWORKS","volume":"32","author":"S Raka","year":"2024","unstructured":"Raka S, Belemkar S, Bhattacharya S (2024) Hybrid Nanoparticles for Cancer Theranostics: A Critical Review on Design, Synthesis, and Multifunctional Capabilities. Curr Med Chem 32:4888\u20134912. https:\/\/doi.org\/10.2174\/0109298673309011240606095639\/CITE\/REFWORKS","journal-title":"Curr Med Chem"},{"key":"12937_CR118","doi-asserted-by":"publisher","unstructured":"Parveen S, Bozal SB, Pober JS, Saltzman WM (2026) Nanoparticle-hydrogel composites for precision medicine. Cell Biomaterials 0. https:\/\/doi.org\/10.1016\/J.CELBIO.2026.100372","DOI":"10.1016\/J.CELBIO.2026.100372"},{"key":"12937_CR119","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1016\/j.nano.2014.03.006","volume":"10","author":"J Shi","year":"2014","unstructured":"Shi J, Xu Y, Xu X et al (2014) Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing. Nanomedicine 10:e897\u2013e900. https:\/\/doi.org\/10.1016\/j.nano.2014.03.006","journal-title":"Nanomedicine"},{"issue":"3 4","key":"12937_CR120","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/S44174-025-00423-0","volume":"4","author":"ER Edwin","year":"2025","unstructured":"Edwin ER, Muthu Y, Sankar P et al (2025) Supramolecular Polymers in Hybrid Drug Delivery Systems: A Promising Platform for Targeted and Responsive Therapeutics. Biomedical Mater Devices 2025 4(3 4):2911\u20132934. https:\/\/doi.org\/10.1007\/S44174-025-00423-0","journal-title":"Biomedical Mater Devices 2025"},{"key":"12937_CR121","doi-asserted-by":"publisher","first-page":"114663","DOI":"10.1016\/J.JCONREL.2026.114663","volume":"392","author":"M Ashford","year":"2026","unstructured":"Ashford M, Bak A (2026) Delivery science: Its increasing importance for the next generation of medicines. J Controlled Release 392:114663. https:\/\/doi.org\/10.1016\/J.JCONREL.2026.114663","journal-title":"J Controlled Release"},{"key":"12937_CR122","doi-asserted-by":"publisher","first-page":"100400","DOI":"10.1016\/J.MEDNTD.2025.100400","volume":"28","author":"I Kamaraj","year":"2025","unstructured":"Kamaraj I, Kamaraj S, Shanmugam G (2025) Emerging strategies and multifunctional applications of nanomaterials in modern nanomedicine. Med Nov Technol Devices 28:100400. https:\/\/doi.org\/10.1016\/J.MEDNTD.2025.100400","journal-title":"Med Nov Technol Devices"},{"key":"12937_CR123","doi-asserted-by":"publisher","first-page":"e70010","DOI":"10.1002\/WNAN.70010","volume":"17","author":"JC Gonzalez","year":"2025","unstructured":"Gonzalez JC, Park KW, Evans DB et al (2025) Nano Approaches to Nucleic Acid Delivery: Barriers, Solutions, and Current Landscape. Wiley Interdiscip Rev Nanomed Nanobiotechnol 17:e70010. https:\/\/doi.org\/10.1002\/WNAN.70010;PAGEGROUP:STRING:PUBLICATION","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"12937_CR124","doi-asserted-by":"publisher","unstructured":"Joyce P, Allen CJ, Alonso MJ et al (2024) A translational framework to DELIVER nanomedicines to the clinic. Nature Nanotechnology 2024 19:11 19:1597\u20131611. https:\/\/doi.org\/10.1038\/s41565-024-01754-7","DOI":"10.1038\/s41565-024-01754-7"},{"key":"12937_CR125","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/S13346-021-01024-2","volume":"12","author":"S \u0110or\u0111evi\u0107","year":"2022","unstructured":"\u0110or\u0111evi\u0107 S, Gonzalez MM, Conejos-S\u00e1nchez I et al (2022) Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res 12:500\u2013525. https:\/\/doi.org\/10.1007\/S13346-021-01024-2","journal-title":"Drug Deliv Transl Res"},{"key":"12937_CR126","doi-asserted-by":"publisher","unstructured":"Hu B, Zhong L, Weng Y et al (2020) Therapeutic siRNA: state of the art. Signal Transduction and Targeted Therapy 2020 5:1 5:101-. https:\/\/doi.org\/10.1038\/s41392-020-0207-x","DOI":"10.1038\/s41392-020-0207-x"},{"key":"12937_CR127","doi-asserted-by":"publisher","first-page":"e084521","DOI":"10.1002\/ALZ.084521","volume":"20","author":"S Cohen","year":"2025","unstructured":"Cohen S, Ducharme S, Brosch JR et al (2025) Single ascending dose results from an ongoing Phase 1 study of mivelsiran (ALN-APP), the first investigational RNA interference therapeutic targeting amyloid precursor protein for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 20:e084521. https:\/\/doi.org\/10.1002\/ALZ.084521","journal-title":"Alzheimer\u2019s Dement"},{"key":"12937_CR128","doi-asserted-by":"publisher","first-page":"e097989","DOI":"10.1002\/ALZ70859_097989","volume":"21","author":"S Cohen","year":"2025","unstructured":"Cohen S, Ducharme S, Brosch JR et al (2025) Multiple-Dose Results from an Ongoing Phase 1 Study of Mivelsiran, an Investigational RNA Interference Therapeutic Targeting Amyloid-Beta Precursor Protein for Alzheimer\u2019s Disease. Alzheimer\u2019s Dement 21:e097989. https:\/\/doi.org\/10.1002\/ALZ70859_097989","journal-title":"Alzheimer\u2019s Dement"},{"key":"12937_CR129","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMOA1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi SJ, Leavitt BR, Landwehrmeyer GB et al (2019) Targeting Huntingtin Expression in Patients with Huntington\u2019s Disease. N Engl J Med 380:2307\u20132316. https:\/\/doi.org\/10.1056\/NEJMOA1900907","journal-title":"N Engl J Med"},{"key":"12937_CR130","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ophtha.2025.07.039","volume":"133","author":"LA Levin","year":"2026","unstructured":"Levin LA, Bhatti MT, Klier S et al (2026) A Randomized Sham-Controlled Phase 2\/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy. Ophthalmology 133:62\u201374. https:\/\/doi.org\/10.1016\/j.ophtha.2025.07.039","journal-title":"Ophthalmology"},{"key":"12937_CR131","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejphar.2015.03.021","volume":"759","author":"TC Burns","year":"2015","unstructured":"Burns TC, Li MD, Mehta S et al (2015) Mouse models rarely mimic the transcriptome of human neurodegenerative diseases: A systematic bioinformatics-based critique of preclinical models. Eur J Pharmacol 759:101\u2013117. https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.021","journal-title":"Eur J Pharmacol"},{"key":"12937_CR132","doi-asserted-by":"publisher","unstructured":"Jaroszynski C, Amer M, Beauchamp A et al (2026) Translating brain anatomy and disease from mouse to human in latent gene expression space. EBioMedicine 127 https:\/\/doi.org\/10.1016\/j.ebiom.2026.106259","DOI":"10.1016\/j.ebiom.2026.106259"},{"key":"12937_CR133","doi-asserted-by":"publisher","first-page":"15723","DOI":"10.1021\/ACSNANO.0C06679","volume":"14","author":"Y Ju","year":"2020","unstructured":"Ju Y, Kelly HG, Dagley LF et al (2020) Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood. ACS Nano 14:15723\u201315737. https:\/\/doi.org\/10.1021\/ACSNANO.0C06679","journal-title":"ACS Nano"},{"key":"12937_CR134","doi-asserted-by":"crossref","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. (2023). The blood-brain barrier: Structure, regulation and drug delivery. Signal transduction and targeted therapy, 8(1), 217.","DOI":"10.1038\/s41392-023-01481-w"},{"key":"12937_CR135","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/S41565-024-01754-7","volume":"19","author":"P Joyce","year":"2024","unstructured":"Joyce P, Allen CJ, Alonso MJ et al (2024) A translational framework to DELIVER nanomedicines to the clinic. Nat Nanotechnol 19:1597\u20131611. https:\/\/doi.org\/10.1038\/S41565-024-01754-7","journal-title":"Nat Nanotechnol"},{"key":"12937_CR136","doi-asserted-by":"crossref","unstructured":"Tang Q, Khvorova A. (2024). RNAi-based drug design: considerations and future directions. Nature reviews Drug discovery, 23(5), 341\u2013364.","DOI":"10.1038\/s41573-024-00912-9"},{"issue":"3","key":"12937_CR137","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/S13346-022-01262-Y","volume":"13","author":"DA Dri","year":"2022","unstructured":"Dri DA, Rinaldi F, Carafa M, Marianecci C (2022) Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes. Drug Delivery Translational Res 2022 13(3):757\u2013769. https:\/\/doi.org\/10.1007\/S13346-022-01262-Y","journal-title":"Drug Delivery Translational Res 2022"},{"key":"12937_CR138","doi-asserted-by":"publisher","unstructured":"Osouli-Bostanabad K, Puliga S, Serrano DR et al (2022) Microfluidic Manufacture of Lipid-Based Nanomedicines. Pharmaceutics 14. https:\/\/doi.org\/10.3390\/PHARMACEUTICS14091940","DOI":"10.3390\/PHARMACEUTICS14091940"},{"key":"12937_CR139","doi-asserted-by":"publisher","unstructured":"Sharifi S, Mahmoud NN, Voke E et al (2022) Importance of Standardizing Analytical Characterization Methodology for Improved Reliability of the Nanomedicine Literature. Nano-Micro Letters 2022 14:1 14:172-. https:\/\/doi.org\/10.1007\/S40820-022-00922-5","DOI":"10.1007\/S40820-022-00922-5"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12937-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12937-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12937-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:22:49Z","timestamp":1792160569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12937-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12937"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12937-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"24 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Artificial intelligence (AI) tools were used solely for English language editing and improvement of figure resolution and image quality. AI was not used for the generation, interpretation, analysis, or modification of the scientific content, results, conclusions, or references. The authors reviewed and approved all final text and figures and take full responsibility for the content of the manuscript.","order":2,"name":"Ethics","label":"AI Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1742"}}